Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Karyopharm Therapeutics Inc. (KPTI)  
$1.09 0.04 (3.54%) as of 4:30 Tue 4/23


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 113,340,000
Market Cap: 123.54(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6758 - $4.09
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 41,140 41,140
Total Buy Value $0 $0 $49,985 $49,985
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 249,038 260,380 305,723 969,198
Total Sell Value $298,412 $307,965 $385,313 $4,260,351
Total People Sold 6 6 6 8
Total Sell Transactions 18 21 33 57
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 592
  Page 1 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rangwala Reshma EVP & Chief Medical Officer   •       –      –    2024-04-22 4 S $1.17 $7,943 D/D (6,789) 342,931 4%     
   Paulson Richard A. President and CEO   •       •      –    2024-04-04 4 S $1.29 $4,596 D/D (3,563) 1,157,273 18%     
   Paulson Richard A. President and CEO   •       •      –    2024-03-05 4 S $1.30 $4,645 D/D (3,573) 1,160,836 12%     
   Poulton Stuart EVP, Chief Development Officer   •       –      –    2024-03-01 4 S $1.20 $7,386 D/D (6,155) 329,511 8%     
   Paulson Richard A. President and CEO   •       •      –    2024-03-01 4 S $1.20 $23,249 D/D (19,374) 1,164,409 8%     
   Cheng Sohanya Roshan EVP & Chief Commercial Officer   •       –      –    2024-03-01 4 S $1.20 $6,131 D/D (5,109) 393,509 8%     
   Mason Michael EVP, CFO & Treasurer   •       –      –    2024-03-01 4 S $1.20 $7,394 D/D (6,162) 398,756 8%     
   Rangwala Reshma EVP & Chief Medical Officer   •       –      –    2024-03-01 4 S $1.20 $7,163 D/D (5,969) 349,720 8%     
   Mano Michael SVP, General Counsel&Secretary   •       –      –    2024-03-01 4 S $1.20 $4,291 D/D (3,576) 277,852 8%     
   Poulton Stuart EVP, Chief Development Officer   •       –      –    2024-02-29 4 S $1.17 $19,084 D/D (16,311) 335,666 6%     
   Paulson Richard A. President and CEO   •       •      –    2024-02-29 4 S $1.17 $94,150 D/D (80,470) 1,183,783 6%     
   Cheng Sohanya Roshan EVP & Chief Commercial Officer   •       –      –    2024-02-29 4 S $1.17 $25,553 D/D (21,840) 398,618 6%     
   Mason Michael EVP, CFO & Treasurer   •       –      –    2024-02-29 4 S $1.17 $32,394 D/D (27,687) 404,918 6%     
   Rangwala Reshma EVP & Chief Medical Officer   •       –      –    2024-02-29 4 S $1.17 $18,330 D/D (15,667) 355,689 6%     
   Mano Michael SVP, General Counsel&Secretary   •       –      –    2024-02-29 4 S $1.17 $19,858 D/D (16,973) 281,428 6%     
   Rangwala Reshma EVP & Chief Medical Officer   •       –      –    2024-02-28 4 A $0.00 $0 D/D 198,959 371,356     -
   Mano Michael SVP, General Counsel&Secretary   •       –      –    2024-02-28 4 A $0.00 $0 D/D 147,000 298,401     -
   Poulton Stuart EVP, Chief Development Officer   •       –      –    2024-02-28 4 A $0.00 $0 D/D 188,205 351,977     -
   Cheng Sohanya Roshan EVP & Chief Commercial Officer   •       –      –    2024-02-28 4 A $0.00 $0 D/D 198,959 420,458     -
   Paulson Richard A. President and CEO   •       •      –    2024-02-28 4 A $0.00 $0 D/D 442,800 1,264,253     -
   Mason Michael EVP, CFO & Treasurer   •       –      –    2024-02-28 4 A $0.00 $0 D/D 188,205 432,605     -
   Mason Michael EVP, CFO & Treasurer   •       –      –    2024-02-27 4 S $1.32 $3,369 D/D (2,545) 244,400 23%     
   Poulton Stuart EVP, Chief Development Officer   •       –      –    2024-02-15 4 S $1.33 $7,783 D/D (5,847) 163,772 16%     
   Mason Michael EVP, CFO & Treasurer   •       –      –    2024-02-06 4 S $1.59 $6,671 D/D (4,205) 246,945 34%     
   Paulson Richard A. President and CEO   •       •      –    2024-02-06 4 S $1.59 $6,365 D/D (4,012) 821,453 34%     
  592 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us